Home » CGT CDMO » Plasmid CDMO Services » Plasmid Manufacture
  • Industrial Leading Timeline

    • Fast turnaround to meet your demanding timeline
      • Plasmid for early clinic: as fast as 4 weeks from strain construction to batch release
      • Plasmid for late clinic & commercial: as fast as 5 weeks from GMP manufacturing to batch release
  • Guaranteed Delivery

    • Guaranteed plasmid quantity and quality – no surprises or hidden costs
    • Dual plasmid manufacturing in US and CN for resilient supply chain and risk mitigation
  • Application-specific Solution

    • Ultra small scale ( 50 mg~200mg) plasmid offering for early-phase trial with no excess waste
    • Excellent ITR integrity (>90%) with proprietary PowerS™-ITRrs strain for AAV transfer plasmid
    • High performing PowerS™-DNA⁺ strain for DNA vaccine with up to 3 g/L

Phase-appropriete Plasmid Manufacturing Service

  • GMP-Principle grade: cost-effective adoption for early clinical phases
  • GMP grade: highest quality, full GMP environment for late clinical and commercial stages
IND
Phase I
Phase II
Phase III
BLA
Commercial
GMP Grade
BLA PC/PV
GMP Grade

* IND Pro for FDA & EMA; GMPro™ for NMPA (China), FDA & EMA

GMP-Principle GMP Plasmid
Animal Free
Antibiotic Free
Fermentation Process
Alkaline Lysis
Chromatographic Purification
CoA (QC Report)
TSE/BSE Statement
Manufacturing Summary Report
E. coli Cell Banking
Process Development,
At-Scale Engineering Run

Proprietary Strains for Various Downstream Applications

Related Service